Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market December 4, 2025 – 7:45 a.m. CET Regulated information Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market Mortsel, Belgium – December 4, 2025 – 7:45 a.m. CET Agfa today announced that it plans to implement additional measures to adjust the cost base of its traditional film activities to the accelerated global market decline. These measures are an extension to the plan that was announced in Novem...
Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt 4 december 2025 – 7:45 uur CET Gereglementeerde informatie Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt Mortsel, België – 4 december 2025 – 7u45 Agfa kondigde vandaag aan dat het van plan is bijkomende maatregelen te nemen om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de versnelde achteruitgang van de wereldwijde markten. Deze...
After three quarters, Agfa's 9M25 “Mature Business” (Radiology and Film DPC) sales dropped -6.4% y/y, driven by the accelerating medical film decline. While its “Growth Engines” (HealthCare IT, Digital Printing Solutions, Green Hydrogen Solutions) are intended to offset this, they also fell -0.9% y/y in the first nine months. We remain cautious (Hold; €1.0 Target Price) until strategic measures deliver and growth engines regain momentum.
Agfa's 3Q25 continued decline in medical film was even stronger than expected (€ 257m 3Q25 sales vs € 275m KBCS & CSS). Although the growth in cloud/SaaS in HealthCare IT all the divisions were below our and CSS forecasts as well on top-line as on REBIT-margins. The increase in Digital Printing & Chemicals was not sufficiently offsetting the impact from the decline in medical film and from cloud transition in HealthCare IT. Despite good cost control, REBIT decreased to -4m, mainly due to the d...
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals Regulated information November 13, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals Group performance: Top line decrease of 7.1% (-4.7% currency comparable): increase in Digital Printing & Chemicals not sufficiently offsetting impact from decline in medical...
De Agfa-Gevaert Groep in het derde kwartaal van 2025: voortdurende achteruitgang in medische film, sterke groei cloud en SaaS in HealthCare IT, zwakkere markten in Digital Print & Chemicals Gereglementeerde informatie 13 november 2025 - 7:45 uur CET De Agfa-Gevaert Groep in het derde kwartaal van 2025: voortdurende achteruitgang in medische film, sterke groei cloud en SaaS in HealthCare IT, zwakkere markten in Digital Print & Chemicals Groepsprestatie: Omzetdaling van 7,1% (-4.7% zonder wisselkoerseffecten): stijging ...
ForFarmers N.V.: ForFarmers trading update Q3 2025 Lochem, 6 November 2025 PRESS RELEASE Trading Update Q3 2025: Solid volume growth and continued strong profitability Pieter Wolleswinkel, CEO ForFarmers: “We look back on a very strong quarter in which we continue the good performance of the past two years. Thanks to our customer-oriented approach and the commitment of our employees, we have once again achieved growth in market share. Recent acquisitions have also contributed to this. Despite the effects of the buyout schemes that are now clearly visible, our compound feed volumes in the...
ForFarmers N.V.: ForFarmers trading update Q3 2025 Lochem, 6 november 2025 PERSBERICHT Trading update Q3 2025: Solide volumegroei en aanhoudend sterke winstgevendheid Pieter Wolleswinkel, CEO ForFarmers: “We kijken terug op een zeer sterk kwartaal, waarin we de goede prestaties van de afgelopen twee jaar hebben voortgezet. Dankzij onze klantgerichte aanpak en de inzet van onze medewerkers hebben we wederom groei in marktaandeel gerealiseerd. Ook de recente overnames droegen hieraan bij. Ondanks de effecten van de stoppersregelingen die nu duidelijk zichtbaar worden, blijven onze mengvoer...
The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film Regulated information August 27, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film Group performance: Strong HealthCare IT performance and stable Digital Print & Chemicals performance not sufficiently offsetting the continued fast decline in medical filmAdjusted EBITDA decreased...
De Agfa-Gevaert Groep in het tweede kwartaal van 2025: Sterke prestatie HealthCare IT, stabiele prestatie Digital Print & Chemicals – verdere achteruitgang medische film Gereglementeerde informatie 27 augustus 2025 - 7:45 uur CET De Agfa-Gevaert Groep in het tweede kwartaal van 2025: Sterke prestatie HealthCare IT, stabiele prestatie Digital Print & Chemicals – verdere achteruitgang medische film Groepsprestatie: Sterke prestatie van HealthCare IT en stabiele prestatie van Digital Print & Chemicals volstaan niet om de ...
Change in composition of the Supervisory Board of ForFarmers Lochem, 12 August 2025 Change in composition of the Supervisory Board of ForFarmers ForFarmers today announces that Erwin Wunnekink, member of the Supervisory Board, has decided to step down from his position as of 1 November 2025. Mr Wunnekink has indicated that he will pursue a new professional opportunity elsewhere, which is not compatible with his role on the Supervisory Board of ForFarmers. "It is unfortunate that Erwin Wunnekink will leave ForFarmers earlier than planned, ahead of his scheduled departure at the AGM in 202...
Wijziging in samenstelling Raad van Commissarissen ForFarmers Lochem, 12 augustus 2025 Wijziging in samenstelling Raad van Commissarissen ForFarmers ForFarmers maakt vandaag bekend dat Erwin Wunnekink, lid van de Raad van Commissarissen, heeft besloten zijn functie per 1 november 2025 neer te leggen. De heer Wunnekink heeft aangegeven een nieuwe professionele uitdaging aan te gaan elders, hetgeen niet te combineren is met zijn rol binnen de Raad van Commissarissen van ForFarmers. "Het is jammer dat we, voortijdig aan zijn geplande aftreden tijdens de AvA in 2027, afscheid moeten nemen va...
ForFarmers results for the first half of 2025 (with full press release) Lochem, 7 August 2025 ForFarmers results for the first half of 2025 Volume rises to 5.2 million tonnes, profitability remains strong Pieter Wolleswinkel, CEO ForFarmers: “The strong development of our results over the past six months confirms that we are on the right track. With a focused execution of our strategy, we are maintaining and expanding our market positions. Thanks in part to the joint venture in Germany, launched in March, and the acquisition of Van Triest Veevoeders in September 2024, we are demonstratin...
Resultaten ForFarmers over eerste halfjaar 2025 (inclusief volledige persbericht) Lochem, 7 augustus 2025 Resultaten ForFarmers over eerste halfjaar 2025Volume stijgt naar 5,2 miljoen ton, winstgevendheid blijft onverminderd sterk Pieter Wolleswinkel, CEO ForFarmers: “De sterke ontwikkeling van onze resultaten in de afgelopen zes maanden bevestigt dat we op de juiste koers zitten. Met een doelgerichte uitvoering van onze strategie behouden en vergroten we onze marktposities. Mede dankzij de joint venture in Duitsland, die in maart is gestart, en de overname van Van Triest Veevoeders in se...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.